VIR
Vir Biotechnology Inc
NASDAQ · Biotechnology
$7.19
+0.27 (+3.90%)
Open$7.06
Previous Close$6.92
Day High$7.40
Day Low$7.04
52W High$10.67
52W Low$4.16
Volume—
Avg Volume1.54M
Market Cap1.01B
P/E Ratio—
EPS$-3.62
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+136.2% upside
Current
$7.19
$7.19
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 76.61M | 187.96M | 123.81M |
| Net Income | -538,918,332 | -1,189,957,062 | -39,256,908 |
| Profit Margin | -703.4% | -668.2% | -31.7% |
| EBITDA | -608,227,928 | -1,417,606,799 | -51,056,784 |
| Free Cash Flow | — | — | -17,401,569 |
| Rev Growth | -59.2% | -59.2% | -9.5% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |